- $245.51m
- $130.45m
- $368.25m
- 93
- 96
- 50
- 94
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 205 | 205 | 321 | 396 | 368 |
Cost of Revenue | |||||
Gross Profit | 74.1 | 31.3 | 23.5 | 29 | 41 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 140 | 182 | 308 | 378 | 341 |
Operating Profit | 65.3 | 22.3 | 12.9 | 17.5 | 27.4 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 79.8 | 31.8 | 15.9 | 13.7 | 37.4 |
Provision for Income Taxes | |||||
Net Income After Taxes | 88.2 | 46.6 | 26.3 | 15.2 | 37.4 |
Net Income Before Extraordinary Items | |||||
Net Income | 88.2 | 46.6 | 26.3 | 15.2 | 37.4 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 88.2 | 46.6 | 26.3 | 15.2 | 37.4 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 2.02 | 1.06 | 0.619 | 0.349 | 0.855 |
Dividends per Share | |||||
Special Dividends per Share |